New Findings Recommend Patients with a Low HIV Viral Load Switch to Second-line Antiretroviral Therapy

Swiss TPH HIV continues to be a major global health issue, having claimed almost 33 million lives. In a new study published today in PLOS Medicine, Swiss TPH researchers and partners assessed if patients with a persisting low HIV viral load while taking first-line antiretroviral therapy (ART) benefited from switching to second-line ART. Findings show that switching patients resulted in a higher proportion of viral suppression, thus encouraging that the World Health Organization (WHO) guidelines lower the current viral load threshold. (Photo: In 2019, 68% of adults and 53% of children with HIV globally were receiving antiretroviral therapy © Dominik Labhardt)

• www.swisstph.ch